Financial statements Eliksir-Pharm
Balance sheet of Eliksir-Pharm
Company age:
Age:
8 y. 8 m. 4 d.
Share capital:
Share capital:
200 000 PLN
Balance sheet data of ELIKSIR-PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 6 283 086,42 | 6 519 399,35 | 4 020 207,91 | 3 547 028,99 | 5 422 349,00 | 5 353 417,12 |
| A. Fixed assets | 4 151 924,40 | 3 610 976,14 | 452 524,59 | 314 448,80 | 432 175,43 | 383 206,04 |
| B. Current assets | 2 131 162,02 | 2 908 423,21 | 3 567 683,32 | 3 232 580,19 | 4 990 173,57 | 4 970 211,08 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 6 283 086,42 | 6 519 399,35 | 4 020 207,91 | 3 547 028,99 | 5 422 349,00 | 5 353 417,12 |
| A. Equity | 3 632 469,62 | 3 438 573,31 | 2 339 212,05 | 1 555 699,26 | 955 029,26 | 853 801,89 |
| B. Liabilities and provisions for liabilities | 2 650 616,80 | 3 080 826,04 | 1 680 995,86 | 1 991 329,73 | 4 467 319,74 | 4 499 615,23 |
| I. Long-term liabilities | 1 104 768,03 | 920 343,00 | 677 080,00 | 269 935,26 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 516 595,17 | 2 129 819,16 | 989 973,67 | 1 721 394,47 | 4 165 070,70 | 4 189 860,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.